Physician profile
Peter Chiusing Hugh
NPI 1316035082
$5,194.78
in general payments reported to CMS, 2019-2025
35 companies · $548 in 2025
The $548 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $897 · 2021: $965 · 2022: $681 · 2023: $845 · 2024: $647 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,040.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,056.02 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $921.37 | 2019-2025 | Trelegy Ellipta, Shingrix, Bexsero |
| Pfizer INC. | $526.91 | 2019-2025 | |
| Lilly USA, LLC | $523.53 | 2019-2025 | Jardiance, Emgality, Mounjaro |
| Janssen Pharmaceuticals, INC | $342.17 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $284.52 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Indivior INC. | $213.45 | 2019-2024 | Sublocade |
| Novo Nordisk INC | $129.78 | 2019-2025 | Ozempic |
| Eisai INC. | $104.33 | 2020-2021 | |
| Abbvie INC. | $101.95 | 2020-2021 | |
| Amarin Pharma, INC. | $88.65 | 2020-2021 | |
| Sanofi Pasteur INC. | $82.09 | 2022-2024 | |
| Cranial Technologies, INC | $78.41 | 2020-2025 | Doc Band |
| Phathom Pharmaceuticals, INC. | $76.50 | 2025 | Voquezna |
| Amgen INC. | $75.62 | 2024-2025 | Otezla, Repatha, Tepezza |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $68.02 | 2022 | |
| Novartis Pharmaceuticals Corporation | $64.43 | 2021-2023 | |
| Exact Sciences Corporation | $61.97 | 2024-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $52.79 | 2025 | Id Now Instrument |
| Abiomed | $32.53 | 2025 | |
| Allergan, INC. | $31.55 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $29.89 | 2025 | Gemtesa |
| Hologic Sales and Service, LLC | $29.22 | 2024 | Thinprep 2000 Processor, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $23.16 | 2024 | |
| Genentech USA, INC. | $22.31 | 2019 | |
| Scilex Pharmaceuticals INC. | $22.06 | 2023 | Ztlido |
| Biohaven Pharmaceuticals, INC. | $22.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.08 | 2023 | Eliquis |
| Horizon Therapeutics Plc | $18.83 | 2022 | |
| Seqirus USA INC | $17.63 | 2021 | |
| Nevro Corp. | $16.69 | 2019 | |
| Vertiflex, INC. | $16.01 | 2019 | |
| Titan Pharmaceuticals, INC. | $15.46 | 2020 | |
| Redhill Biopharma INC. | $13.10 | 2020 | |
| Optos, INC. | $11.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Hugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.